Pulmonx (LUNG) Change in Accured Expenses (2019 - 2025)

Pulmonx (LUNG) has reported Change in Accured Expenses for 7 consecutive years, with $528000.0 the latest figure, recorded in Q3 2025.

• On a quarterly basis, Change in Accured Expenses fell 27.87% year-over-year to $528000.0 in Q3 2025; TTM through Sep 2025 was $2.1 million, a 269.71% increase from a year earlier, with the FY2024 full-year figure at $462000.0, down 85.45% from the prior year.
• Change in Accured Expenses was $528000.0 for Q3 2025 at Pulmonx, down from $2.5 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $4.0 million in Q4 2024 and troughed at -$6.0 million in Q1 2024.
• A 5-year average of $355315.8 and a median of $1.0 million in 2022 frame the typical range for Change in Accured Expenses.
• Across the five-year window, Change in Accured Expenses surged 237.32% in 2021 and slumped 357.53% in 2022, its largest moves.
• Over 5 years, Change in Accured Expenses stood at $1.5 million in 2021, then soared by 58.05% to $2.4 million in 2022, then fell by 5.53% to $2.3 million in 2023, then soared by 76.48% to $4.0 million in 2024, then tumbled by 86.72% to $528000.0 in 2025.
• The last three Change in Accured Expenses figures came in at $528000.0 (Q3 2025), $2.5 million (Q2 2025), and -$4.9 million (Q1 2025), per Business Quant data.